Prescription for a Stronger F.D.A.
NYT-FDA92806.pdf | 24.2 kB
September 28, 2006
A prestigious advisory group has put its weight behind criticism that the Food and Drug Administration is pitifully weak when it comes to removing dangerous prescription drugs from the market. Last week, a panel appointed by the Institute of Medicine, part of the National Academy of Sciences, issued a slew of recommendations to strengthen the beleaguered F.D.A. as it struggles to regulate a huge array of medications whose ill effects sometimes show up only after years of wide use.
The New York Times